Elevated prenatal homocysteine levels as a risk factor for schizophrenia

Archives of General Psychiatry

Volumn 64, Issue 1, 2007, Pages 31-39

  Brown, Alan S ^a,b,e   Bottiglieri, Teodoro ^c   Schaefer, Catherine A ^d   Quesenberry Jr , Charles P ^d   Liu, Liyan ^d   Bresnahan, Michaeline ^b   Susser, Ezra S ^a,b  

^a New York State Psychiatric Institute ^*  (United States)

^b Columbia University ^*  (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d DIVISION OF RESEARCH   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; MEASUREMENT; MOTHER FETUS RELATIONSHIP; PLACENTA FUNCTION; PREGNANCY COMPLICATION; PRENATAL CARE; RISK ASSESSMENT; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCREENING; STATISTICAL ANALYSIS; VITAMIN SUPPLEMENTATION;

ADULT; CASE-CONTROL STUDIES; CHILD; CHILD OF IMPAIRED PARENTS; COHORT STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; RISK FACTORS; SCHIZOPHRENIA;

EID: 33845993973     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.64.1.31     Document Type: Article

References (64)

1. Brown AS, Bresnahan M, Susser ES. Schizophrenia: environmental epidemiology. In: Sadock BJ, Sadock VA, eds. Comprehensive Textbook of Psychiatry. 8th ed. Baltimore, Md: Lippincott, Williams, & Wilkins; 2005:1371-80.
2. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry. 2002;159:1080-1092.
3. Brown AS, Susser ES. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev. 2002;8:51-57.
4. Brown AS, Begg MD, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M, Babulas VP, Susser ES. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774-780.
5. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, Gorman JM. Schizophrenia after prenatal famine: further evidence. Arch Gen Psychiatry. 1996;53:25-31.
6. Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P. Signs of asphyxia at birth and risk of schizophrenia: population-based case-control study. Br J Psychiatry. 2001;179:403-408.
7. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR, Stamler JS. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997;94:5923-5928.
8. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry. 2001;158:1367-1377.
9. Wang C, Anastasio N, Popov V, Leday A, Johnson KM. Blockade of N-methyl-D-aspartate receptors by phencyclidine causes the loss of corticostriatal neurons. Neuroscience. 2004;125:473-483.
10. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis: role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731-741.
11. Nelen WLDM, Bulten J, Steegers EAP, Blom HJ, Hanselaar AGJM, Eskes TKAB. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod. 2000;15:954-960.
12. Holmes VA. Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis? Proc Nutr Soc. 2003;62:479-493.
13. Starkebaum G, Harlan JM. Endothelial-cell injury due to copper-catalyzed hydrogen-peroxide generation from homocysteine. J Clin Invest. 1986;77:1370-1376.
14. Parnetti L, Bottiglieri T, Lowenthal D. Role of homocysteine in age-related vascular and non-vascular diseases. Aging (Milano). 1997;9:241-257.
15. di Simone N, Riccardi P, Maggiano N, Piacentani A, D'Asta M, Capelli A, Caruso A. Effect of folic acid on homocysteine-induced trophoblast apoptosis. Mol Hum Reprod. 2004;10:665-669.
16. Mercuri E, Ricci D, Cowan FM, Lessing D, Frisone MF, Haataja L, Counsell SJ, Dubowitz LM, Rutherford MA. Head growth in infants with hypoxic-ischemic encephalopathy: correlation with neonatal magnetic resonance imaging. Pediatrics. 2000;106:235-243.
17. Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy: review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Biol. 2000;93:157-165.
18. El Khodor BF, Flores G, Srivastava LK, Boksa P. Effects of birth insult and stress at adulthood on excitatory amino acid receptors in adult rat brain. Synapse. 2004;54:138-146.
19. Mallard EC, Waldvogel HJ, Williams CE, Faull RL, Gluckman PD. Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain. Neuroscience. 1995;65:827-836.
20. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr. 2000;71:962-968.
21. Laivuori H, Kaaja R, Turpeinen U, Viinikka L, Ylikorkala O. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol. 1999;93:489-493.
22. Susser ES, Schaefer CA, Brown AS, Begg MD, Wyatt RJ. The design of the prenatal determinants of schizophrenia study. Schizophr Bull. 2000;26:257-273.
23. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience. 2001;107:535-550.
24. Andersen JD, Pouzet B. Spatial memory deficits induced by perinatal treatment of rats with PCP and reversal effect of D-serine. Neuropsychopharmacology. 2004;29:1080-1090.
25. Baschat AA. Fetal responses to placental insufficiency: an update. BJOG. 2004;111:1031-1041.
26. Murphy MM, Scott JM, Arija V, Molloy AM, Fernandez-Ballart JD. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birthweight. Clin Chem. 2004;50:1406-1412.
27. van den Berg BJ. The California Child Health and Development Studies: twenty years of research. World Health Stat Q. 1979;32:269-286.
28. van den Berg BJ. The California Child Health and Development Studies. In: Mednick SA, Harway M, Finello K, eds. Handbook of Longitudinal Research. New York, NY: Praeger; 1984:166-179.
29. O'Suilleabhain PE, Sung V, Hernandez C, Lacritz L, Dewey RB Jr, Bottiglieri T, az-Arrastia R. Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations. Arch Neurol. 2004;61:865-868.
30. Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 1994;309:699-703.
31. Jones P, Rodgers B, Murray R, Marmot M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994;344:1398-1402.
32. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. IQ and risk for schizophrenia: a population-based cohort study. Psychol Med. 1997;27:1311-1323.
33. Kendler KS, Neale MC, Walsh D. Evaluating the spectrum concept of schizophrenia in the Roscommon Family Study. Am J Psychiatry. 1995;152:749-754.
34. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. Diagnostic interview for genetic studies: rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry. 1994;51:849-859.
35. Martin SC, Hilton AC, Bartlett WA, Jones AF. Plasma total homocysteine measurement by ion-paired reversed-phase HPLC with electrochemical detection. Biomed Chromatogr. 1999;13:81-82.
36. Kelsey JL, Thompson WD, Evans AS. Monographs in Epidemiology and Biostatistics. New York, NY: Oxford University Press; 1986.
37. Breslow NE, Day NE. Statistical methods in cancer research, Volume I: the analysis of case-control studies. IARC Sci Publ. 1980;32:5-338.
38. Self S, Mauritsen R, Ohara J. Power calculations for likelihood ratio tests in generalized linear models. Biometrics. 1992;48:31-39.
39. EGRET: a program for sample size power estimation. Statistics and Epidemiology Research Corporation. 2003.
40. Olney JW. Fetal alcohol syndrome at the cellular level. Addict Biol. 2004;9:137-149.
41. Harris LW, Sharp T, Gartlon J, Jones DN, Harrison PJ. Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci. 2003;18:1706-1710.
42. Harrison PJ. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain. 1999;122:593-624.
43. Picker JD, Coyle JT. Do maternal folate and homocysteine levels play a role in neurodevelopmental processes that increase risk for schizophrenia? Harv Rev Psychiatry. 2005;13:197-205.
44. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest. 1986;77:1909-1916.
45. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991;88:1906-1914.
46. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Hyperhomocyst(e) inemia and endothelial dysfunction in IDDM. Diabetes Care. 1998;21:841-848.
47. Kamudhamas A, Pang L, Smith SD, Sadovsky Y, Nelson DM. Homocysteine thiolactone induces apoptosis in cultured human trophoblasts: a mechanism for homocysteine-mediated placental dysfunction? Am J Obstet Gynecol. 2004;191:563-571.
48. Dalman C, Allebeck P, Cullberg J, Grunewald C, Koster M. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch Gen Psychiatry. 1999;56:234-240.
49. Jones PB, Rantakallio P, Hartikainen AL, Isohanni M, Sipila P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. Am J Psychiatry. 1998;155:355-364.
50. Graham I. Homocysteine Metabolism: From Basic Science to Clinical Medicine. Boston, Mass: Kluwer Academic Publishers; 1997.
51. Lewis CA, Pancharuniti N, Sauberlich HE. Plasma folate adequacy as determined by homocysteine level. Ann N Y Acad Sci. 1992;669:360-362.
52. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG. Accelerated folate breakdown in pregnancy. Lancet. 1993;341:148-149.
53. Goff DC, Bottiglieri T, Arning E, Shih V, Freudenreich O, Evins AE, Henderson DC, Baer L, Coyle J. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry. 2004;161:1705-1708.
54. Regland B, Johansson BV, Grenfeldt B, Hjelmgren LT, Medhus M. Homocysteinemia is a common feature of schizophrenia. J Neural Transm Gen Sect. 1995;100:165-169.
55. Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry. 2002;159:1790-1792.
56. Susser E, Brown AS, Klonowski E, Allen RH, Lindenbaum J. Schizophrenia and impaired homocysteine metabolism: a possible association. Biol Psychiatry. 1998;44:141-143.
57. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002;288:2023-2031.
58. Parnetti L, Caso V, Santucci A, Corea F, Lanari A, Floridi A, Conte C, Bottiglieri T. Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci. 2004;25:13-17.
59. Tan EC, Chong SA, Lim LC, Chan AO, Teo YY, Tan CH, Mahendran R. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr Genet. 2004;14:227-231.
60. Virgos C, Martorell L, Simo JM, Valero J, Figuera L, Joven J, Labad A, Vilella E. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. Neuroreport. 1999;10:2035-2038.
61. Molloy AM, Mills JL, McPartlin J, Kirke PN, Scott JM, Daly S. Maternal and fetal plasma homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5,10-methylenetetrahydrofolate reductase 677C→T variant. Am J Obstet Gynecol. 2002;186:499-503.
62. St Clair D, Xu M, Wang P, Yu Y, Fang Y, Zhang F, Zheng X, Gu N, Feng G, Sham P, He L. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA. 2005;294:557-562.
63. Brown AS, Susser ES, Butler PD, Richardson AR, Kaufmann CA, Gorman JM. Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J Nerv Ment Dis. 1996;184:71-85.
64. Holmes VA, Wallace JM, Alexander HD, Gilmore WS, Bradbury I, Ward M, Scott JM, McFaul P, McNulty H. Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin Chem. 2005;51:629-634.